Rankings
▼
Calendar
VTRS Q4 2021 Earnings — Viatris Inc. Revenue & Financial Results | Market Cap Arena
VTRS
Viatris Inc.
$17B
Q4 2021 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$4.3B
+19.8% YoY
Gross Profit
$1.5B
35.6% margin
Operating Income
-$78M
-1.8% margin
Net Income
-$264M
-6.1% margin
EPS (Diluted)
$-0.22
QoQ Revenue Growth
-4.3%
Cash Flow
Operating Cash Flow
$523M
Free Cash Flow
$302M
Stock-Based Comp.
$23M
Balance Sheet
Total Assets
$54.8B
Total Liabilities
$34.4B
Stockholders' Equity
$20.5B
Cash & Equivalents
$701M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$4.3B
$3.6B
+19.8%
Gross Profit
$1.5B
$706M
+118.9%
Operating Income
-$78M
-$881M
+91.2%
Net Income
-$264M
-$916M
+71.2%
Revenue Segments
Brands
$2.6B
60%
Generics
$1.4B
32%
Complex GX and Biosimilars
$348M
8%
Geographic Segments
Developed Markets Segment
$2.6B
59%
Emerging Markets Segment
$728M
17%
Japan, Australia and New Zealand Segment
$539M
12%
Greater China Segment
$504M
12%
← FY 2021
All Quarters
Q1 2022 →